Real-world data on the effectiveness and safety of teriflunomide in patients with relapsing–remitting multiple sclerosis: The EFFECT study; [Datos del mundo real sobre la efectividad y seguridad de teriflunomida en pacientes con esclerosis múltiple remite
ISSN
26670496
Date Issued
2022
DOI
10.1016/j.neurop.2022.06.001
Subjects